Heidi Ko/LinkedIn
Jun 10, 2025, 08:58
Heidi Ko: Exploring the Future of Precision Oncology with Labcorp Perspectives
Heidi Ko, Medical Director of Medical Affairs at Labcorp Drug Development, shared a post on LinkedIn:
“It’s not every day you get to work alongside the best humans: the kind of team that brings not only deep expertise but also true collaboration, curiosity, and a shared sense of purpose.
I was incredibly fortunate to be part of a recent episode on Labcorp Perspectives in Oncology! Rebecca Previs and I delved into just how far precision oncology has come with tumor agnostic biomarkers and therapies and how much further we can go.
If you’re interested in where oncology is headed, this might be a discussion worth listening to.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 21, 2025, 11:40
Aug 21, 2025, 11:15
Aug 21, 2025, 10:23
Aug 21, 2025, 10:08
Aug 21, 2025, 09:30
Aug 21, 2025, 08:17
Aug 21, 2025, 06:29